MegaChem Limited - Annual Report 2025

The attendance of the Directors at scheduled Board Committee and Board meetings held in FY 2025 is set out below: Board Audit Committee Nominating Committee Remuneration Committee No. of Meetings Held No. of Meetings Attended No. of Meetings Held No. of Meetings Attended No. of Meetings Held No. of Meetings Attended No. of Meetings Held No. of Meetings Attended Mr Sidney Chew Choon Tee 4 4 2 NA 1 1 1 NA Mr Yeo Wee Kiong 4 4 2 2 1 1 1 1 Mr Sim Guan Seng 4 4 2 2 1 1 1 1 Mr Daniel Loh Hong Chye 4 4 2 2 1 NA 1 1 Mr Yasutaka Kawamura 4 4 2 NA 1 NA 1 NA When a Director has multiple board representations, the NC also considers whether or not the Director is able to and has adequately carried out his duties as a Director of the Company. The NC is satisfied that sufficient time and attention has been given by the Directors to the affairs of the Company, notwithstanding that some of the Directors have multiple board representations. The NC is of the view that the matter relating to multiple board representations should be left to the judgement of each Director given that time requirements for different board representations vary. As such, the NC and the Board have decided that there is no necessity to determine the maximum number of listed company board representations which a Director may hold. None of the Directors hold more than 4 directorships in listed companies concurrently. Provision 1.6 of the Code: Access to information The Company recognises that the flow of relevant, complete and accurate information on a timely basis is critical for the Board to discharge its duties effectively. The Management provides the Board with quarterly management accounts, as well as relevant background or explanatory information relating to the matters that would be discussed at the Board meetings, prior to the scheduled meetings. All Directors are also furnished with updates on the financial position and any material developments of the Group as and when necessary. Provision 1.7 of the Code: Access to Management and Company Secretary The Board has separate and independent access to the Company Secretary and the Management at all times. The Board will have independent access to professional advice when required at the Company’s expense, subject to the approval of the Chairman. Under the direction of the Chairman, the Company Secretary facilitates information flow within the Board and its Board Committees and between the Management and Non-Executive Directors. The Company Secretary attends all meetings of the Board and Board committees and ensures that all Board procedures are followed and applicable rules and regulations are complied with. The minutes of all Board committee meetings are circulated to the Board. The appointment and removal of the Company Secretary is subject to the approval of the Board as a whole. MEGACHEM LIMITED ANNUAL REPORT 2025 55 CORPORATE GOVERNANCE REPORT

RkJQdWJsaXNoZXIy NTM2MDQ5